Details for 2019203616

Up to date per 02.04.2026

Actions

Title / Product Name

CEFTOLOZAN/TAZOBACTAM ZUR BEHANDLUNG INTRAPULMONALER INFEKTIONEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019203616

EP Publication Number

3616695

E-Number

1734271

Language

PCT Number

Publication Date

04.03.2020 A

23.10.2024 B1

Registration Date

23.10.2024

AT Publication Date

15.11.2024

Application Date

07.09.2012

Registration Number

Priorities

09.09.2011

201161532914 P

08.06.2012

201261657386 P

IPC

A61K 31/397 20060101AFI20200123BHEP

Maximum Duration of Protection

07.09.2032

Owner

Merck Sharp & Dohme LLC126 East Lincoln Avenue Rahway, New Jersey 07065US

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

CHANDORKAR, Gurudatt, A.267 Bishops Forest Drive Waltham, MA Massachusetts 02452US

HUNTINGTON, Jennifer, A.55 Grand Street Reading, MA Massachusetts 01867US

PARSONS, Tara32 Shingle Mill Lane Hanover, MA Massachusetts 02339US

UMEH, Obiamiwe, C.57 Stoneymeade Way Acton, MA Massachusetts 01720US

Information about Fees